1mg, best e pharmacy in India

ROWASA 500MG SACHET

Sachet
Rs.18.50for 1 packet(s) (1 sachet each)
1
Unfortunately, we don't have any more items in stock
Report Error

Composition FOR ROWASA 500mg sachet

Mesalazine(500mg)

food interaction for ROWASA sachet

alcohol interaction for ROWASA sachet

pregnancy interaction for ROWASA sachet

lactation interaction for ROWASA sachet

medicine interaction for ROWASA sachet

food
alcohol
pregnancy
lactation
medicine
It is better to take Rowasa 500mg sachet with food.
Interaction with alcohol is unknown. Please consult your doctor.
Rowasa 500mg sachet may be unsafe to use during pregnancy.
Animal studies have shown adverse effects on the foetus, however, there are limited human studies. The benefits from use in pregnant women may be acceptable despite the risk. Please consult your doctor.
WEIGH RISKS VS. BENEFITS
Unknown. Human and animal studies are not available. Please consult your doctor.
  • SERIOUS INTERACTION
    IMURAN 50MG TABLET, PURINETONE 50MG TABLET, AZAP 50MG TABLET & 7 more
  • SALT INFORMATION FOR ROWASA 500mg sachet

    Mesalazine(500mg)

    Rowasa sachet uses

    Rowasa 500mg sachet is used in the treatment of ulcerative colitis and crohn’s disease.

    How rowasa sachet works

    Rowasa 500mg sachet blocks the release of chemical messengers that cause inflammation of the lining of the intestines.

    Common side effects of rowasa sachet

    Nausea, Headache, Diarrhoea, Abdominal pain

    COMMON DOSAGE FOR ROWASA 500MG SACHET

    Patients taking ROWASA 500MG SACHET

    • 53%
      Twice A Day
    • 20%
      Once A Day
    • 13%
      Thrice A Day
    • 7%
      Twice A Week
    • 7%
      Thrice A week

    SUBSTITUTES FOR ROWASA sachet

    1 Substitutes
    1 Substitutes
    Sorted By
    RelevancePrice
    • ETIASA 500MG SACHET
      (1 GM sachet in packet)
      Novartis India Ltd
      Rs. 9.30/GM of sachet
      generic_icon
      Rs. 9.30
      save 50% more per GM of sachet

    Top Rheumatologists

    Expert advice FOR ROWASA sachet

    • Do not take the medicine if you are allergic to mesalazine, to any other content in the medicine, aspirin and other salicylate drugs.
    • Do not take mesalazine if you have severe kidney or liver problems, blood disorders or uncontrolled bleeding.
    • Do not take mesalazine if you have stomach or bowel ulcers or a history of bleeding ulcers, glucose-galactose mala absorption, Lapp-lactase deficiency or galactose intolerance.
    • Doctor’s advice should be considered in case of patients with liver, kidney or lung disease (asthma).
    • Avoid taking mesalazine if you are pregnant or planning to become pregnant or breast-feeding.

    Frequently asked questions FOR ROWASA 500mg sachet

    Mesalazine

    Q. Is mesalazine a steroid, NSAID, immunosuppressant, blood-thinner or sulfa drug?
    Mesalazine is not a steroid, NSAID, immunosuppressant, blood-thinner or sulfa drug. It is an anti-inflammatory drug
    Q. Can I take mesalazine forever?
    No. Mesalazine should only be taken for the duration prescribed by your doctor
    Q. Is mesalazine safe?
    Yes. Mesalazine is relatively safe if used as recommended. In case of any side-effects, consult your doctor
    Show More
    Q. Can I take Asacol with Advil, Nyquil, tylenol, aspirin, Gaviscon, Imodium?
    Asacol (mesalazine) can be taken with Nyquil, Tylenol (paracetamol), Gaviscon (sodium alginate) and Imodium (loperamide) only if prescribed by your doctor. It should not be taken with Advil (ibuprofen) or aspirin
    Q. Does mesalazine cause bleeding, weight gain, hair loss, immune suppression or liver problems?
    Mesalazine may cause liver problems, immune suppression, hair loss, or bleeding. If you experience any such symptoms, please consult your doctor
    Q. Does mesalazine affect fertility or sperm count?
    There is no evidence of mesalazine affecting fertility, but it may very rarely and reversibly reduce sperm count. If you experience any such problems, please consult your doctor.

    Articles


    Content on this page was last updated on 04 May, 2017, by Dr. Varun Gupta (MD Pharmacology)